Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000245062

Medchemexpress LLC Regorafenib monohydrate | 1019206-88-2 | MFCD17170366 | 99.7% | 500.83 g/mol | C21H17ClF4N4O4 | 5 MG
SDP

Catalog No. 5000245062
Encompass_Preferred

Regorafenib monohydrate is the monohydrate form of regorafenib, a multi-targeted receptor tyrosine kinase inhibitor supplied for laboratory research use. The product is provided as a characterized solid with accompanying COA, SDS, and handling documentation. Not for human or veterinary use.

  • High purity (LCMS 99.67% reported in COA).
  • Molecular weight 500.83 g/mol.
  • Molecular formula C21H17ClF4N4O4.
  • Off-white to light brown solid with supporting NMR and LCMS data.
  • Available in small research sizes and solution formats.
  • Supplied with COA, SDS, and storage instructions for research use only.

Catalog No. 50-002-45062 Supplier Medchemexpress LLC Supplier No. HY10331A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Regorafenib monohydrate is the monohydrate form of regorafenib, a multi-targeted receptor tyrosine kinase inhibitor supplied for laboratory research use. The product is provided as a characterized solid with accompanying COA, SDS, and handling documentation. Not for human or veterinary use.

  • High purity (LCMS 99.67% reported in COA).
  • Molecular weight 500.83 g/mol.
  • Molecular formula C21H17ClF4N4O4.
  • Off-white to light brown solid with supporting NMR and LCMS data.
  • Available in small research sizes and solution formats.
  • Supplied with COA, SDS, and storage instructions for research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.